
News|Articles|August 21, 2015
Suresh Ramalingam on Toxicities Associated With Immunotherapy in Different Disease Types
Author(s)Suresh S. Ramalingam
Key Takeaways
- Immunotherapy offers significant advantages over traditional cancer treatments but presents unique toxicity profiles requiring distinct management strategies.
- Immune-related toxicities can affect various organ systems, necessitating vigilant monitoring and intervention by oncologists.
Suresh S. Ramalingam, a professor of medical oncology at the Winship Cancer Institute of Emory University, comments on the difference in toxicities associated with immunotherapy.
Advertisement
Suresh S. Ramalingam, a professor of medical oncology at the Winship Cancer Institute of Emory University, comments on the difference in toxicities associated with immunotherapy.
Advertisement
Advertisement
Advertisement
Trending on CURE
1
Most Patients With HER2+ Breast Cancer Miss Standard Treatment, Study Shows
2
FDA Fast Tracks LBL-034 in Relapsed or Refractory Multiple Myeloma
3
Expert insights into Biomarker-Driven Care and Emerging Targets in GI Cancer
4
A Breast Cancer Survivor’s First Brush with Skin Cancer
5




